Literature DB >> 27821668

Generation of Immunity against Pathogens via Single-Domain Antibody-Antigen Constructs.

Joao N Duarte1, Juan J Cragnolini1, Lee Kim Swee1, Angelina M Bilate1, Justin Bader1, Jessica R Ingram1, Ali Rashidfarrokhi1, Tao Fang1, Ariën Schiepers1, Leo Hanke1, Hidde L Ploegh2.   

Abstract

mAbs specific for surface proteins on APCs can serve as Ag-delivery vehicles that enhance immunogenicity. The practical use of such constructs is limited by the challenge of expressing and modifying full-sized mAbs. We generated single-domain Ab fragments (VHHs) specific for class II MHC (MHCII), CD11b, and CD36. VHH sequences were modified by inclusion of a C-terminal sortase motif to allow site-specific conjugation with various Ag payloads. We tested T cell activation using VHHs that target distinct APC populations; anti-MHCII adducts elicited strong activation of CD4+ T cells, whereas anti-CD11b showed CD8+ T cell activation superior to targeting via MHCII and CD36. Differences in Ag presentation among constructs were unrelated to dendritic cell subtype or routing to acidic compartments. When coupled to antigenic payloads, anti-MHCII VHH primed Ab responses against GFP, ubiquitin, an OVA peptide, and the α-helix of influenza hemagglutinin's stem; the last afforded protection against influenza infection. The versatility of the VHH scaffold and sortase-mediated covalent attachment of Ags suggests their broader application to generate desirable immune responses.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27821668      PMCID: PMC5806123          DOI: 10.4049/jimmunol.1600692

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

1.  Differential lysosomal proteolysis in antigen-presenting cells determines antigen fate.

Authors:  Lélia Delamarre; Margit Pack; Henry Chang; Ira Mellman; E Sergio Trombetta
Journal:  Science       Date:  2005-03-11       Impact factor: 47.728

2.  Differential antigen processing by dendritic cell subsets in vivo.

Authors:  Diana Dudziak; Alice O Kamphorst; Gordon F Heidkamp; Veit R Buchholz; Christine Trumpfheller; Sayuri Yamazaki; Cheolho Cheong; Kang Liu; Han-Woong Lee; Chae Gyu Park; Ralph M Steinman; Michel C Nussenzweig
Journal:  Science       Date:  2007-01-05       Impact factor: 47.728

3.  Modulation of protein properties in living cells using nanobodies.

Authors:  Axel Kirchhofer; Jonas Helma; Katrin Schmidthals; Carina Frauer; Sheng Cui; Annette Karcher; Mireille Pellis; Serge Muyldermans; Corella S Casas-Delucchi; M Cristina Cardoso; Heinrich Leonhardt; Karl-Peter Hopfner; Ulrich Rothbauer
Journal:  Nat Struct Mol Biol       Date:  2009-12-13       Impact factor: 15.369

4.  Antigen targeting to CD11b+ dendritic cells in association with TLR4/TRIF signaling promotes strong CD8+ T cell responses.

Authors:  Gilles Dadaglio; Catherine Fayolle; Xiaoming Zhang; Bernard Ryffel; Marine Oberkampf; Tristan Felix; Sandra Hervas-Stubbs; Radim Osicka; Peter Sebo; Daniel Ladant; Claude Leclerc
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

5.  Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype.

Authors:  Mireille H Lahoud; Fatma Ahmet; Susie Kitsoulis; Soo San Wan; David Vremec; Chin-Nien Lee; Belinda Phipson; Wei Shi; Gordon K Smyth; Andrew M Lew; Yu Kato; Scott N Mueller; Gayle M Davey; William R Heath; Ken Shortman; Irina Caminschi
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

6.  Sortase-mediated modification of αDEC205 affords optimization of antigen presentation and immunization against a set of viral epitopes.

Authors:  Lee Kim Swee; Carla P Guimaraes; Sharvan Sehrawat; Eric Spooner; M Inmaculada Barrasa; Hidde L Ploegh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-07       Impact factor: 11.205

Review 7.  Nanobodies: natural single-domain antibodies.

Authors:  Serge Muyldermans
Journal:  Annu Rev Biochem       Date:  2013-03-13       Impact factor: 23.643

8.  Dendritic cell and macrophage heterogeneity in vivo.

Authors:  Daigo Hashimoto; Jennifer Miller; Miriam Merad
Journal:  Immunity       Date:  2011-09-23       Impact factor: 31.745

9.  A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins.

Authors:  Davide Corti; Jarrod Voss; Steven J Gamblin; Giosiana Codoni; Annalisa Macagno; David Jarrossay; Sebastien G Vachieri; Debora Pinna; Andrea Minola; Fabrizia Vanzetta; Chiara Silacci; Blanca M Fernandez-Rodriguez; Gloria Agatic; Siro Bianchi; Isabella Giacchetto-Sasselli; Lesley Calder; Federica Sallusto; Patrick Collins; Lesley F Haire; Nigel Temperton; Johannes P M Langedijk; John J Skehel; Antonio Lanzavecchia
Journal:  Science       Date:  2011-07-28       Impact factor: 47.728

10.  Route of antigen uptake differentially impacts presentation by dendritic cells and activated monocytes.

Authors:  Alice O Kamphorst; Pierre Guermonprez; Diana Dudziak; Michel C Nussenzweig
Journal:  J Immunol       Date:  2010-08-20       Impact factor: 5.422

View more
  22 in total

1.  Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune Responses.

Authors:  Andrew W Woodham; Ross W Cheloha; Jingjing Ling; Mohammad Rashidian; Stephen C Kolifrath; Maia Mesyngier; Joao N Duarte; Justin M Bader; Joseph G Skeate; Diane M Da Silva; W Martin Kast; Hidde L Ploegh
Journal:  Cancer Immunol Res       Date:  2018-05-23       Impact factor: 11.151

Review 2.  Exploring cellular biochemistry with nanobodies.

Authors:  Ross W Cheloha; Thibault J Harmand; Charlotte Wijne; Thomas U Schwartz; Hidde L Ploegh
Journal:  J Biol Chem       Date:  2020-08-31       Impact factor: 5.157

3.  Recognition of Class II MHC Peptide Ligands That Contain β-Amino Acids.

Authors:  Ross W Cheloha; Andrew W Woodham; Djenet Bousbaine; Tong Wang; Shi Liu; John Sidney; Alessandro Sette; Samuel H Gellman; Hidde L Ploegh
Journal:  J Immunol       Date:  2019-08-07       Impact factor: 5.422

4.  Noninvasive Imaging of Human Immune Responses in a Human Xenograft Model of Graft-Versus-Host Disease.

Authors:  Catharina H M J Van Elssen; Mohammad Rashidian; Vladimir Vrbanac; Kai W Wucherpfennig; Zeina El Habre; Jana Sticht; Christian Freund; Johanne T Jacobsen; Juanjo Cragnolini; Jessica Ingram; Loes Plaisier; Eric Spierings; Andrew M Tager; Hidde L Ploegh
Journal:  J Nucl Med       Date:  2017-02-16       Impact factor: 10.057

Review 5.  Nanobodies in cancer.

Authors:  Elisha R Verhaar; Andrew W Woodham; Hidde L Ploegh
Journal:  Semin Immunol       Date:  2020-11-30       Impact factor: 11.130

Review 6.  Variegated Outcomes of T Cell Activation by Dendritic Cells in the Steady State.

Authors:  Jessica Bourque; Daniel Hawiger
Journal:  J Immunol       Date:  2022-02-01       Impact factor: 5.426

7.  The activity of myeloid cell-specific VHH immunotoxins is target-, epitope-, subset- and organ dependent.

Authors:  Christopher Bachran; Matthias Schröder; Lena Conrad; Juan J Cragnolini; Fikadu G Tafesse; Laura Helming; Hidde L Ploegh; Lee Kim Swee
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.996

8.  Nanobody immunostaining for correlated light and electron microscopy with preservation of ultrastructure.

Authors:  Tao Fang; Xiaotang Lu; Daniel Berger; Christina Gmeiner; Julia Cho; Richard Schalek; Hidde Ploegh; Jeff Lichtman
Journal:  Nat Methods       Date:  2018-11-05       Impact factor: 28.547

9.  Induction of antigen-specific tolerance by nanobody-antigen adducts that target class-II major histocompatibility complexes.

Authors:  Thibault Harmand; Liyan Y Smeding; Novalia Pishesha; Weiyi Ma; Leif S Ludwig; Robine Janssen; Ashraful Islam; Yushu J Xie; Tao Fang; Nicholas McCaul; William Pinney; Harun R Sugito; Martin A Rossotti; Gualberto Gonzalez-Sapienza; Hidde L Ploegh
Journal:  Nat Biomed Eng       Date:  2021-06-14       Impact factor: 25.671

10.  Targeted antigen delivery by an anti-class II MHC VHH elicits focused αMUC1(Tn) immunity.

Authors:  Tao Fang; Catharina H M J Van Elssen; Joao N Duarte; Jonathan S Guzman; Jasdave S Chahal; Jingjing Ling; Hidde L Ploegh
Journal:  Chem Sci       Date:  2017-05-26       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.